Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.
Essy MozaffariAastha ChandakZhiji ZhangShuting LiangMark ThrunRobert L GottliebDaniel R KuritzkesPaul E SaxDavid A WohlRoman CascianoPaul HodgkinsRichard HaubrichPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
RDV initiated upon hospital admission was associated with improved survival among COVID-19 patients. Our findings complement ACTT-1 and support RDV as a foundational treatment for hospitalized COVID-19 patients.